Akèy › Obèsite › Kansas › Wichita
Etid klinik pou Obèsite nan Wichita, KS
11 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote Wichita (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
Ap rekriteFaz 2
- AMR Clinical - Wichita, Wichita
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Ap rekriteFaz 3
- Research Site, Newton · 24 mi lwen
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Ap rekriteFaz 3
- AMR Clinical, Newton · 24 mi lwen
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Ap rekriteFaz 3
- Kansas Nephrology Research Institute LLC, Wichita
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Ap rekriteFaz 3Volontè an sante akeyi
- ACCOMPLISH-2 Research Site, Wichita
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Ap rekriteFaz 3
- Kailera Clinical Site, Newton · 24 mi lwen
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Ap rekriteFaz 3
- Alliance for Multispecialty Research Newton, Newton · 24 mi lwen
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Ap rekriteFaz 3
- Alliance for Multispecialty Research LLC, Wichita
- Alliance for Multispecialty Research Newton, Newton · 24 mi lwen
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Ap rekriteFaz 3
- Kailera Clinical Site, Newton · 24 mi lwen
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Ap rekriteFaz 3
- West Houston Area Clinical Trial Consultants, Wichita
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Ap rekriteFaz 3
- ACCOMPLISH-1 Research Site, Wichita
Etid Obèsite nan lòt vil
- Houston, TX43 etid
- Chicago, IL41 etid
- New York City, NY40 etid
- San Antonio, TX40 etid
- Washington, DC33 etid
- Orlando, FL31 etid
- Dallas, TX30 etid
- Boston, MA28 etid
- Las Vegas, NV27 etid
- Miami, FL27 etid
- Baltimore, MD25 etid
- Jacksonville, FL25 etid
Lòt etid nan Wichita
- Dyabèt Tip 210 etid
- Ensifizyans kadyak8 etid
- Hypertension artérielle8 etid
- Sipwa8 etid
- Maladi atè koronè7 etid
- Kansè Poumon ki pa ti selil5 etid
- Kansè poumon5 etid
- Kansè nan tete5 etid
- Stenoz valv aòt5 etid
- Maladi kadyovaskilè4 etid
- Kansè kolorektal4 etid
- Maladie de Huntington3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.